Soleno Therapeutics (SLNO) Assets: 2013-2019
Historic Assets for Soleno Therapeutics (SLNO) over the last 5 years, with Sep 2019 value amounting to $28.7 million.
- Soleno Therapeutics' Assets fell 6.84% to $28.7 million in Q3 2019 from the same period last year, while for Sep 2019 it was $28.7 million, marking a year-over-year decrease of 6.84%. This contributed to the annual value of $43.2 million for FY2018, which is 10.58% up from last year.
- Latest data reveals that Soleno Therapeutics reported Assets of $28.7 million as of Q3 2019, which was down 15.85% from $34.1 million recorded in Q2 2019.
- Soleno Therapeutics' 5-year Assets high stood at $43.2 million for Q4 2018, and its period low was $5.5 million during Q2 2016.
- Over the past 3 years, Soleno Therapeutics' median Assets value was $33.9 million (recorded in 2017), while the average stood at $34.1 million.
- Its Assets has fluctuated over the past 5 years, first tumbled by 36.89% in 2016, then spiked by 601.22% in 2017.
- Over the past 5 years, Soleno Therapeutics' Assets (Quarterly) stood at $8.2 million in 2015, then plummeted by 32.15% to $5.6 million in 2016, then skyrocketed by 601.22% to $39.0 million in 2017, then rose by 10.58% to $43.2 million in 2018, then fell by 6.84% to $28.7 million in 2019.
- Its Assets stands at $28.7 million for Q3 2019, versus $34.1 million for Q2 2019 and $38.9 million for Q1 2019.